The Antimicrobial Peptide Cathelicidin Protects Mice from Escherichia coli O157:H7-Mediated Disease

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Chromek, Milan ^a   Arvidsson, Ida ^a   Karpman, Diana ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE CRAMP; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; SHIGA TOXIN; UNCLASSIFIED DRUG;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASYMPTOMATIC DISEASE; BACTERIAL COUNT; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; FECES ANALYSIS; IN VITRO STUDY; INFECTION PREVENTION; INFECTION SENSITIVITY; INTESTINE MUCOSA PERMEABILITY; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; MICROBIAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN DEPLETION; STRAIN DIFFERENCE; SYMPTOM; THROMBOCYTOPENIA; TISSUE REACTION;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, KNOCKOUT; MICROBIAL SENSITIVITY TESTS;

EID: 84867521053     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046476     Document Type: Article

References (50)

1. Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, et al. (1988) Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med 109: 705-712.
2. Jerse AE, Yu J, Tall BD, Kaper JB, (1990) A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci U S A 87: 7839-7843.
3. Nataro JP, Kaper JB, (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142-201.
4. Karpman D, Sartz L, Johnson S, (2010) Pathophysiology of typical hemolytic uremic syndrome. Semin Thromb Hemost 36: 575-585.
5. Ståhl AL, Sartz L, Nelsson A, Bekassy ZD, Karpman D, (2009) Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS One 4: e6990.
6. Obrig TG, Karpman D, (2011) Shiga toxin pathogenesis: Kidney complications and renal failure. Curr Top Microbiol Immunol.
7. Pennington H, (2010) Escherichia coli O157. Lancet 376: 1428-1435.
8. Zasloff M, (2002) Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.
9. Gudmundsson GH, Agerberth B, Odeberg J, Bergman T, Olsson B, et al. (1996) The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 238: 325-332.
10. Gallo RL, Kim KJ, Bernfield M, Kozak CA, Zanetti M, et al. (1997) Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 272: 13088-13093.
11. Kai-Larsen Y, Luthje P, Chromek M, Peters V, Wang X, et al. (2010) Uropathogenic Escherichia coli modulates immune responses and its curli fimbriae interact with the antimicrobial peptide LL-37. PLoS Pathog 6: e1001010.
12. Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, et al. (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76: 4176-4182.
13. Kin NW, Chen Y, Stefanov EK, Gallo RL, Kearney JF, (2011) Cathelin-related antimicrobial peptide differentially regulates T- and B-cell function. Eur J Immunol 41: 3006-3016.
14. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, et al. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414: 454-457.
15. Chromek M, Slamova Z, Bergman P, Kovacs L, Podracka L, et al. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 12: 636-641.
16. Iimura M, Gallo RL, Hase K, Miyamoto Y, Eckmann L, et al. (2005) Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol 174: 4901-4907.
17. Hase K, Eckmann L, Leopard JD, Varki N, Kagnoff MF, (2002) Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 70: 953-963.
18. Koon HW, Shih DQ, Chen J, Bakirtzi K, Hing TC, et al. (2011) Cathelicidin Signaling via the Toll-like Receptor Protects Against Colitis in Mice. Gastroenterology 141: 1852-1863 e1853.
19. Islam D, Bandholtz L, Nilsson J, Wigzell H, Christensson B, et al. (2001) Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 7: 180-185.
20. O'Brien AD, Melton AR, Schmitt CK, McKee ML, Batts ML, et al. (1993) Profile of Escherichia coli O157:H7 pathogen responsible for hamburger-borne outbreak of hemorrhagic colitis and hemolytic uremic syndrome in Washington. J Clin Microbiol 31: 2799-2801.
21. Karpman D, Connell H, Svensson M, Scheutz F, Alm P, et al. (1997) The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis 175: 611-620.
22. Bekassy ZD, Calderon Toledo C, Leoj G, Kristoffersson A, Leopold SR, et al. (2011) Intestinal damage in enterohemorrhagic Escherichia coli infection. Pediatr Nephrol 26: 2059-2071.
23. Calderon Toledo C, Rogers TJ, Svensson M, Tati R, Fischer H, et al. (2008) Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. Am J Pathol 173: 1428-1439.
24. Johansson ME, Larsson JM, Hansson GC, (2011) The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A 108 Suppl 1: 4659-4665.
25. Thompson KL, Applegate TJ, (2006) Feed withdrawal alters small-intestinal morphology and mucus of broilers. Poult Sci 85: 1535-1540.
26. Tai EK, Wong HP, Lam EK, Wu WK, Yu L, et al. (2008) Cathelicidin stimulates colonic mucus synthesis by up-regulating MUC1 and MUC2 expression through a mitogen-activated protein kinase pathway. J Cell Biochem 104: 251-258.
27. Frankel G, Phillips AD, Rosenshine I, Dougan G, Kaper JB, et al. (1998) Enteropathogenic and enterohaemorrhagic Escherichia coli: more subversive elements. Mol Microbiol 30: 911-921.
28. Savage DC, (1977) Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31: 107-133.
29. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI, (2005) Host-bacterial mutualism in the human intestine. Science 307: 1915-1920.
30. Louis P, Scott KP, Duncan SH, Flint HJ, (2007) Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 102: 1197-1208.
31. Schauber J, Svanholm C, Termen S, Iffland K, Menzel T, et al. (2003) Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 52: 735-741.
32. Kankainen M, Paulin L, Tynkkynen S, von Ossowski I, Reunanen J, et al. (2009) Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein. Proc Natl Acad Sci U S A 106: 17193-17198.
33. Bishop JR, Gagneux P, (2007) Evolution of carbohydrate antigens-microbial forces shaping host glycomes? Glycobiology 17: 23R-34R.
34. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, et al. (2008) The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci U S A 105: 15064-15069.
35. Otte JM, Zdebik AE, Brand S, Chromik AM, Strauss S, et al. (2009) Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul Pept 156: 104-117.
36. Jager S, Stange EF, Wehkamp J, (2010) Antimicrobial peptides in gastrointestinal inflammation. Int J Inflam 2010: 910283.
37. Meyer-Hoffert U, Hornef MW, Henriques-Normark B, Axelsson LG, Midtvedt T, et al. (2008) Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 57: 764-771.
38. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, et al. (1999) Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286: 113-117.
39. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL, (2003) Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422: 522-526.
40. Motto DG, Chauhan AK, Zhu G, Homeister J, Lamb CB, et al. (2005) Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest 115: 2752-2761.
41. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI, (2000) The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342: 1930-1936.
42. Bitzan M, (2009) Treatment options for HUS secondary to Escherichia coli O157:H7. Kidney Int Suppl: S62-66.
43. Mukhopadhyay S, Linstedt AD, (2012) Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis. Science 335: 332-335.
44. Lapeyraque AL, Malina M, Fremeaux-Bacchi V, Boppel T, Kirschfink M, et al. (2011) Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 364: 2561-2563.
45. Hertting O, Holm A, Luthje P, Brauner H, Dyrdak R, et al. (2010) Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PLoS One 5: e15580.
46. Raqib R, Sarker P, Bergman P, Ara G, Lindh M, et al. (2006) Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A 103: 9178-9183.
47. Talukder P, Satho T, Irie K, Sharmin T, Hamady D, et al. (2011) Trace metal zinc stimulates secretion of antimicrobial peptide LL-37 from Caco-2 cells through ERK and p38 MAP kinase. Int Immunopharmacol 11: 141-144.
48. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, et al. (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173: 2909-2912.
49. Sarker P, Ahmed S, Tiash S, Rekha RS, Stromberg R, et al. (2011) Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy. PLoS One 6: e20637.
50. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.